¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"autoimmune thrombocytopenia purpura"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
¿µ¹® autoimmune dieases ÇÑ±Û ÀÚ°¡¸é¿ªÁúȯ
¼³¸í   
  ¸é¿ªÀ̶õ ¿Ü°è¿¡¼­ µé¾î¿Â ¹°ÁúÀ» ÆÄ±«Çϰųª ¹«±â·ÂÈ­ ½ÃÄѼ­ ÀÚ½ÅÀ» º¸È£Çϴ ÀÏ·ÃÀÇ ÀÛ¿ëÀ» ¸»ÇÑ´Ù. ¸é¿ª¿¡¼­ °¡Àå Áß¿äÇÑ ´Ü°è´Â ÀڽŰú ¿ÜºÎ¿¡¼­ µé¾î¿Â ¹°ÁúÀ» ±¸ºÐÇϴ °ÍÀÌ´Ù. ÀÚ°¡ ¸é¿ªÁúȯÀ̶õ ÀÌ·± ÀڽŰú ¿ÜºÎ¿¡¼­ µé¾î¿Â ¹°ÁúÀÇ ±¸ºÐÀÌ È®½ÇÇÏÁö ¸øÇÏ¿© ÀÚ½ÅÀÇ ¹°Áú·Î À߸ø ÀνÄÇÏ¿© ½º½º·Î ÀÚ½ÅÀÇ ¹°ÁúÀ» ÆÄ±«Çϴ º´À» ¸»ÇÑ´Ù.
¿µ¹® purpura ÇÑ±Û ÀÚ»ö¹ÝÁõ
¼³¸í   
  ÇǺγ»ÀÇ ÃâÇ÷·Î ÀÎÇÏ¿©, ÇǺΠǥÇǸ¦ ÅëÇÏ¿© ½±°Ô º¸À̴ ÀÚÈ«»ö È¤Àº Àû°¥»ö ¹ÝÁ¡À» Æ¯Â¡À¸·Î Çϴ ÀÏ·ÃÀÇ ÁúȯÀ» ÃÑĪÇϴ ¿ë¾îÀÌ´Ù. ´ë°³ È«¹Ý°ú ±¸º°ÇؾߠÇϴ µ¥ È«¹ÝÀº ÇǺιØÀÇ Ç÷°üÀÌ ÆØÃ¢ÇÏ¿© ºÓ°Ô º¸À̴ Çö»óÀ¸·Î Åõ¸íÇÑ ÀÚ¸¦ ÀÌ¿ëÇÏ¿© ÇǺθ¦ ´­·¯¼­ °üÂûÇØº¸¸é ½±°Ô ±¸º°ÀÌ °¡´ÉÇÏ´Ù. À̶§ È«¹ÝÀº ºÓÀº »öÀÌ ¾ø¾îÁöÁö¸¸, ÀÚ¹ÝÀº ºÓÀº »öÀÌ ¾ø¾îÁöÁö ¾Ê´Â´Ù.
  
  
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • amegakaryocytic thrombocytopenia
    ¹«°Å´ëÇÙ¼¼Æ÷Ç÷¼ÒÆÇ°¨¼Ò(Áõ)
  • essential thrombocytopenia
    º»ÅÂÇ÷¼ÒÆÇ°¨¼Ò(Áõ)
  • immune thrombocytopenia
    ¸é¿ª¼ºÇ÷¼ÒÆÇ°¨¼Ò(Áõ)
  • neonatal alloimmune thrombocytopenia
    ½Å»ý¾Æµ¿Á¾¸é¿ªÇ÷¼ÒÆÇ°¨¼Ò(Áõ)
  • neonatal thrombocytopenia
    ½Å»ý¾ÆÇ÷¼ÒÆÇ°¨¼Ò(Áõ)
  • post-transfusion thrombocytopenia
    ¼öÇ÷ÈÄÇ÷¼ÒÆÇ°¨¼Ò(Áõ)
  • autoimmune
    ÀÚ°¡¸é¿ª-
  • autoimmune antibody
    ÀÚ°¡¸é¿ªÇ×ü
  • autoimmune disease
    ÀÚ°¡¸é¿ªÁúȯ
  • autoimmune disorder
    ÀÚ°¡¸é¿ªÁúȯ
  • autoimmune hemolytic anemia
    ÀÚ°¡¸é¿ª¿ëÇ÷ºóÇ÷
  • autoimmune hepatitis
    ÀÚ°¡¸é¿ª°£¿°
  • autoimmune inner ear disease
    ÀÚ°¡¸é¿ª¼Ó±Íº´, ÀÚ°¡¸é¿ª³»ÀÌÁúȯ
  • autoimmune progesterone dermatitis
    ÀÚ°¡¸é¿ªÇÁ·Î°Ô½ºÅ×·ÐÇǺο°
  • autoimmune reaction
    ÀÚ°¡¸é¿ª¹ÝÀÀ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 8 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • thrombocytopenia
    ÀúÇ÷¼ÒÆÇÁõ
  • autoimmune antibody
    ÀÚ°¡¸é¿ªÇ×ü
  • autoimmune response
    ÀÚ°¡¸é¿ª¹ÝÀÀ
  • Henoch-Schoenlein purpura nephritis
    Çì³ëÈ彨¶óÀÎÀÚ»ö¹ÝÄáÆÏ¿°, Çì³ëÈ彨¶óÀÎÀÚ»ö¹Ý½ÅÀå¿°
  • purpura
    ÀÚ»ö¹Ý, ÀÚ»ö¹Ýº´
  • Henoch-Schonlein purpura
    Çì³ëÈ£½¨¶óÀÎÀÚ»ö¹Ý
  • immune thrombocytopenic purpura
    ¸é¿ªÇ÷¼ÒÆÇ°¨¼ÒÀÚ»ö¹Ý
  • palpable purpura
    ÃËÁöÀÚ»ö¹Ý
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • amegakaryocytic thrombocytopenia
    ¹«°Å´ëÇÙ¼¼Æ÷ÀúÇ÷¼ÒÆÇÁõ
  • immune thrombocytopenia
    ¸é¿ªÀúÇ÷¼ÒÆÇÁõ
  • neonatal thrombocytopenia
    ½Å»ý¾ÆÀúÇ÷¼ÒÆÇÁõ
  • neonatal alloimmune thrombocytopenia
    ½Å»ý¾Æµ¿Á¾¸é¿ªÀúÇ÷¼ÒÆÇÁõ
  • post-transfusion thrombocytopenia
    ¼öÇ÷ÈÄÀúÇ÷¼ÒÆÇÁõ
  • thrombocytopenia
    ÀúÇ÷¼ÒÆÇÁõ
  • autoimmune
    ÀÚ°¡¸é¿ª-
  • autoimmune disease
    ÀÚ°¡¸é¿ªº´
  • autoimmune hepatitis
    (¢¡chronic active hepatitis) ¸¸¼ºÈ°µ¿°£¿°
  • autoimmune reaction
    ÀÚ°¡¸é¿ª¹ÝÀÀ
  • autoimmune response
    ÀÚ°¡¸é¿ª¹ÝÀÀ
  • autoimmune antibody
    ÀÚ°¡¸é¿ªÇ×ü
  • autoimmune hemolytic anemia
    ÀÚ°¡¸é¿ª¿ëÇ÷ºóÇ÷
  • autoimmune inner ear disease
    ÀÚ°¡¸é¿ª¼Ó±Íº´
  • autoimmune progesterone dermatitis
    ÀÚ°¡¸é¿ªÇÁ·Î°Ô½ºÅ×·ÐÇǺο°
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • amegakaryocytic thrombocytopenia
    ¹«°ÅÇÙ±¸¼º Ç÷¼ÒÆÇ°¨¼ÒÁõ(ÙíËÝú·Ï¹àõúìá³÷ùÊõá´ñø).
  • amegakaryocytic thrombocytopenia
    ¹«°ÅÇÙ±¸¼º Ç÷¼ÒÆÇ°¨¼ÒÁõ(ËÎ˧̴˴ËÛÌ´ËÛ̬˧ËÛÌ¡).
  • hemangioma thrombocytopenia syndrome
    Ç÷°üÁ¾Ç÷¼ÒÆÇ°¨¼ÒÁõÈıº.
  • hemorrhagic diathesis,thrombocytopenia
    Ç÷¼ÒÆÇ°¨¼ÒÁõ(¡­Êõá´ñø)
  • immune thrombocytopenia
    ¸é¿ªÇ÷¼ÒÆÇ°áÇÌÁõ
  • post-transfusion thrombocytopenia
    ¼öÇ÷ÈÄÇ÷¼ÒÆÇ°¨¼ÒÁõ
  • Henoch s purpura
    Çì³ëÈ£Àڹݺ´.
  • TTP=£¾thrombotic thrombocytopenic purpura
    Ç÷Àü¼º Ç÷¼ÒÆÇ°¨¼ÒÀÚ¹ÝÁõ.
  • allergic purpura
    ¾Ë·¹¸£±â(¼º) ÀÚ¹ÝÁõ(í¹Úèñø)
  • anaphylactoid purpura
    ¾Æ³ªÇʶô½Ã¾ç Àڹݺ´(¡­í¹ÚèÜ»)
  • anaphylactoid purpura
    ¾Æ³ªÇʶô½Ã¾ç Àڹݺ´(¡­í¹ÚèÜ»).
  • annularis telangiectodes purpura
    ¸ð¼¼Ç÷°ü È®À强 ȯ»óÀÚ¹Ý
  • gangrenous purpura
    ±«Àú¼º ÀÚ¹Ý(¡­í¹Úè)
  • hemorrhagic purpura
    ÃâÇ÷(¼º) ÀÚ¹Ý(º´)
  • henoch-schonlein purpura
    Çì³ëÈ£-½¦¶óÀÎ (Henoch-Schonlein) ÀÚ¹ÝÁõ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • autoimmune thrombocytopenia=AITP
    ÀÚ°¡¸é¿ª¼ºÇ÷¼ÒÆÇ °¨¼ÒÁõ
  • thrombocytopenia purpura hemorrhagica ³ª
    ÃâÇ÷¼º Ç÷¼ÒÆÇ°¨¼Ò¼º ÀÚ¹ÝÁõ(õóúìàõúìá³÷ùÊõá´àõí¹Úèñø)
  • purulent purpura = suppurative purpura
    È­³ó¼ºÀÚ¹Ý
  • alloimmune neonatal thrombocytopenia=ANN
    µ¿Á¾¸é¿ª¼º½Å»ý¾ÆÇ÷¼ÒÆÇ°¨¼ÒÁõ
  • amegakaryocytic thrombocytopenia
    ¹«°ÅÇÙ±¸¼º Ç÷¼ÒÆÇ°¨¼ÒÁõ(ÙíËÝú·Ï¹àõúìá³÷ùÊõá´ñø).
  • amegakaryocytic thrombocytopenia
    ¹«°ÅÇÙ±¸¼º Ç÷¼ÒÆÇ°¨¼ÒÁõ(ËÎ˧̴˴ËÛÌ´ËÛ̬˧ËÛÌ¡).
  • congenital immunologic thrombocytopenia
    ¼±Ãµ¼º ¸é¿ª¼º Ç÷¼ÒÆÇ°¨¼ÒÁõ(¡­Øóæ¹ àõúìá³÷ùÊõá´ñø).
  • hemangioma thrombocytopenia syndrome
    Ç÷°üÁ¾Ç÷¼ÒÆÇ°¨¼ÒÁõÈıº.
  • hemorrhagic diathesis,thrombocytopenia
    Ç÷¼ÒÆÇ°¨¼ÒÁõ(¡­Êõá´ñø)
  • immune thrombocytopenia
    ¸é¿ªÇ÷¼ÒÆÇ°áÇÌÁõ
  • neonatal alloimmune thrombocytopenia=NAIT
    ½Å»ý¾Æµ¿Á¾¸é¿ªÇ÷¼ÒÆÇ °áÇÌÁõ
  • post-transfusion thrombocytopenia
    ¼öÇ÷ÈÄÇ÷¼ÒÆÇ°¨¼ÒÁõ
  • secondary thrombocytopenia
    ÀÌÂ÷¼º Ç÷¼ÒÆÇ°¨¼ÒÁõ.
  • secondary thrombocytopenia
    ÀÌÂ÷¼º Ç÷¼ÒÆÇ°¨¼ÒÁõ(úìáÈ÷ùÊõá´ñø)
  • thrombocytopenia
    Ç÷¼ÒÆÇ°¨¼ÒÁõ(úìá³÷úÊõá´ñø), Ç÷Àü±¸(úìîûϹ)°¨¼ÒÁõ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • autoimmune complement fixation
    ÀÚ°¡¸é¿ª (í»Ê«Øóæ¹) º¸Ã¼°íÁ¤ (ÜÍô÷ͳïÒ)
  • autoimmune disease
    ÀÚ°¡¸é¿ªÁúȯ (í»Ê«Øóæ¹òðü´)
  • autoimmune response
    ÀÚ°¡¸é¿ª´ëÀÀ (í»Ê«Øóæ¹Óßëë)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 7 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • autoimmune
    ÀÚ°¡¸é¿ª
  • hemorrhagic purpura
    ÃâÇ÷¼ºÀڹݺ´
  • Henoch's purpura
    Çì³ëÈ£Àڹݺ´
  • idiopathic thrombocytopenic purpura
    Ư¹ß¼ºÇ÷¼ÒÆÇ °¨¼Ò¼º Àڹݺ´
  • purpura
    ÀÚ¹Ý, Àڹݺ´
  • thrombasthenic purpura
    Ç÷¼ÒÆÇÃë¾à¼º Àڹݺ´
  • thrombocytopenic purpura
    Ç÷¼ÒÆÇ°¨¼Ò¼ºÀÚ¹ÝÁõ
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
ITP idiopathic thrombocytopenic purpura; immune thrombocytopenia; immunogenic thrombocytopenic purpura; ...
ATP   1) Adenosine Tri-Phosphate
  2) Autoimmune Thrombocytopenic Purpura
AITP autoimmune idiopathic thrombocytopenic purpura
ATP adenosine triphosphate; ambient temperature and pressure; autoimmune thrombocytopenic purpura
AID acquired immunodeficiency disease; acute infectious disease; acute ionization detector; Agency for I...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
AITP Autoimmune thrombocytopenia
AITP Autoimmune thrombocytopenic purpura
ATP Autoimmune thrombocytopenic purpura
HSP Henoch Schonlein Purpura
HSPN Henoch-Schoenlein purpura nephritis
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • idiopathic thrombocytopenia
    Ư¹ß¼º Ç÷¼ÒÆÇ °¨¼ÒÁõ
  • neonatal alloimmune thrombocytopenia
    ½Å»ý¾Æ µ¿Á¾ ¸é¿ª Ç÷¼ÒÆÇ °áÇÌÁõ
  • post-transfusion thrombocytopenia
    ¼öÇ÷ÈÄ Ç÷¼ÒÆÇ °¨¼ÒÁõ
  • primary thrombocytopenia
    ¿ø¹ß¼º Ç÷¼ÒÆÇ °¨¼ÒÁõ
  • secondary thrombocytopenia
    ÀÌÂ÷¼º Ç÷¼ÒÆÇ °¨¼ÒÁõ
  • thrombocytopenia
    Ç÷¼ÒÆÇ °¨¼ÒÁõ, Ç÷Àü±¸ °¨¼ÒÁõ
    Ç÷¾× ³» Ç÷¼ÒÆÇÀÇ ¼ýÀÚ°¡ °¨¼ÒÇÏ´Â °Í.
  • autoimmune
    ÀÚ°¡ ¸é¿ª
    ÀÚ°¡ ¸é¿ª¿¡ °üÇÑ.
  • autoimmune blood dyscrasia
    ÀÚ°¡ ¸é¿ª¼º Ç÷¾× ÀÌ»ó
  • autoimmune disorder
    ÀÚ°¡ ¸é¿ª Àå¾Ö
    ½Åü°¡ ÀÚ±â Àڽſ¡ ´ëÇØ Àå¾Ö°¡ ÀÖ´Â ¸é¿ª ¹ÝÀÀÀ» ÀÏÀ¸ÄÑ ·ù¸¶Æ¼¼º °üÀý¿°, ÇǺΠ°æÈ­Áõ°ú °°ÀÌ ÀÚ½ÅÀÇ Á¶Á÷ ÆÄ±«¸¦ À¯¹ßÇÏ´Â Áúȯ.
  • autoimmune hemolytic disease
    ÀÚ°¡ ¸é¿ª¼º ¿ëÇ÷¼º Áúȯ
  • autoimmune progesterone dermatitis
    ÀÚ°¡ ¸é¿ª ÇÁ·Î°Ô½ºÅ×·Ð ÇǺο°
  • autoimmune reaction
    ÀÚ°¡ ¸é¿ª ¹ÝÀÀ
  • autoimmune thyroiditis
    ÀÚ°¡ ¸é¿ª¼º °©»ó¼±¿°
  • polyendocrine autoimmune disease
    ´Ù³»ºÐºñ¼± ÀÚ°¡ ¸é¿ª Áúȯ
    µ¿ÀǾî=autoimmune
  • warm-antibody autoimmune hemolytic anemia
    ¿Â³­ Ç×ü ÀÚ°¡¸é¿ª¼º ¿ëÇ÷¼º ºóÇ÷
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
autoimmune thrombocytopenia purpura <haematology> A rare autoimmune disorder characterised by an acute shortage of platelets with resultant bruising and spontaneous bleeding.
The platelet count becomes exceedingly low and spontaneous bleeding from the gums, gastrointestinal tract and nose can be seen. Physical examination may demonstrate enlargement of the spleen. A typical rash occurs to do microscopic haemorrhage of small blood vessels in the skin.
Platelet counts under 10,000 can lead to spontaneous haemorrhage into the brain causing death. Treatment with corticosteroids is generally effective. Surgical removal of the spleen (splenectomy) is reserved for some patients.
Anti-platelet antibodies are detectable in some cases. It may present in either an acute or a chronic form.
Acronym: ITP
(20 Sep 2002)
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
idiopathic thrombocytopenia purpura <haematology> A rare autoimmune disorder characterised by an acute shortage of platelets with resultant bruising and spontaneous bleeding.
The platelet count becomes exceedingly low and spontaneous bleeding from the gums, gastrointestinal tract and nose can be seen. Physical examination may demonstrate enlargement of the spleen. A typical rash occurs to do microscopic haemorrhage of small blood vessels in the skin.
Platelet counts under 10,000 can lead to spontaneous haemorrhage into the brain causing death. Treatment with corticosteroids is generally effective. Surgical removal of the spleen (splenectomy) is reserved for some patients.
Anti-platelet antibodies are detectable in some cases. It may present in either an acute or a chronic form.
Acronym: ITP
(20 Sep 2002)
thrombocytopenia purpura <haematology> In severe thrombocytopenia, bleeding into skin leads to small petechial haemorrhages.
Primary thrombocytopenia purpura is of unknown cause but results from an autoimmune mechanism that causes platelet destruction.
Secondary thrombocytopenic purpura may result from drug-induced type II hypersensitivity in which platelets coated with antibody to the drug (which is acting as a hapten) are destroyed in a complement mediated reaction. It can also follow a viral upper respiratory infection and may be seen in association with lupus.
(15 Oct 1997)
anaemia, haemolytic, autoimmune Acquired haemolytic anaemia due to the presence of autoantibodies which agglutinate or lyse the patient's own red cells.
(12 Dec 1998)
autoimmune <immunology> Pertaining to autoimmunity.
(02 Jan 1998)
autoimmune disease <disease> A disease process that involves the production of host antibodies to host tissue.
(27 Sep 1997)
autoimmune diseases Are illnesses which occur when the body tissues are attacked by its own immune system. The immune system is a complex organisation within the body that is designed normally to seek and destroy invaders of the body, particularly infections. Patients with these diseases have unusual antibodies in their blood that target their own body tissues.
(12 Dec 1998)
autoimmune haemolytic anaemia <haematology> A condition that results from the cellular destruction (haemolysis) of red blood cells due to antibodies formed to components on the surface of the red blood cells.
Origin: Gr. Haima = blood
(02 Jan 1998)
autoimmune hepatitis <pathology> A type of chronic active hepatitis that results from circulating auto-antibodies and chronic inflammation of the liver.
Symptoms are those of chronic active hepatitis.
(27 Sep 1997)
autoimmune thyroiditis <endocrinology> Inflammation of the thyroid gland without the formation of pus. Noninfectious nonbacterial thyroid inflammation.
(27 Sep 1997)
polyendocrinopathies, autoimmune Autoimmune disease affecting multiple endocrine organs. Type I is characterised by childhood onset and mucocutaneous candidiasis, while type II exhibits any combination of adrenal insufficiency (addison's disease), lymphocytic thyroiditis, hypoparathyroidism, and gonadal failure. In both types organ-specific antibodies against a variety of endocrine glands have been detected. The type II syndrome differs from type I in that it is associated with HLA-a1 and b8 haplotypes, onset is usually in adulthood, and candidiasis is not present.
(12 Dec 1998)
hepatitis, autoimmune An unresolving, predominately periportal, hepatitis, usually with hypergammaglobulinaemia and serum autoantibodies. The existence of subgroups (types 1, 2, and 3) based on serological findings are controversial. Additionally, some patients have variant forms, where there are features associated with both autoimmune hepatitis and another type of chronic liver disease (overlap syndromes) or where there are findings incompatible with autoimmune hepatitis (outlier syndromes).
(12 Dec 1998)
systemic autoimmune diseases A group of connective tissue disease's characterised by the presence of autoantibodies responsible for immunopathologically mediated tissue lesions; systemic lupus erythematosus is the prototype.
(05 Mar 2000)
thyroiditis, autoimmune A progressive disease of the thyroid gland with antibodies in the blood stream directed against the thyroid and infiltration of the gland by lymphoctes (a key type of white blood cells involved in the immune response). This immune response is against one's own thyroid. (it is autoimmune.) predominantly affects women. Can be familial. Also called hashimoto's disease or hashimoto's thyroiditis.
(12 Dec 1998)
canine infectious cyclic thrombocytopenia An infection of dogs with the rickettsia Ehrlichia platys characterised by recurrent cyclic thrombocytopenia.
(05 Mar 2000)
radial aplasia-thrombocytopenia syndrome <syndrome> Aplasia (absence) of the radius (the long bone on the thumb-side of the forearm) and thrombocytopenia (low blood platelets) are key features characterizing this syndrome. There is phocomelia (flipper-limb) with the thumbs always present. The fibula (the smaller bone in the lower leg) is often absent. The risk of bleeding from too few platelets is high in early infancy but lessens with age. The condition is inherited in an autosomal recessive trait with one gene (on a non-sex chromosome) coming from each parent to the child affected with the disease. Alternative names include thrombocytopenia-absent radius syndrome, tar syndrome, and tetraphocomelia-thrombocytopenia syndrome.
(12 Dec 1998)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • autoimmune
    ÀÚ±â(ÀÚ°¡)¸é¿ªÀÇ
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á